跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 219 条关于
“Avacta”
全部
219
临床试验
111
药物
41
机构
18
资讯
49
去年
Avacta's pre|CISION™ Platform Shows Promise in Targeted Cancer Therapy
去年
Avacta Completes Transition to Pure-Play Therapeutics with £2.2M Coris Sale
去年
Avacta Group Advances Oncology Pipeline with Novel Therapies and AI Collaboration
去年
Avacta Therapeutics Sells Launch Diagnostics for £12.9M to Focus on Cancer Drug Development
前天
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
去年
Avacta's AVA6000 Shows Promise in Targeted Cancer Therapy
3年前
Avacta Acquires Belgium-Based Coris BioConcept for £7.4 Million to Expand Diagnostics Portfolio
去年
Avacta Therapeutics Raises £3.25 Million and Secures Bond Amendment to Advance FAP-Dox Cancer Therapy
11个月前
Avacta Develops First Dual-Payload Peptide Drug Conjugate Platform for Cancer Combination Therapy
去年
Avacta Strengthens Leadership Team with Appointment of Chief Medical Officer and Business Development Advisor
第 1 页,共 5 页
上一页
下一页